Albireo Pharma Inc Propriété institutionnelle
Quel est le Propriété institutionnelle de Albireo Pharma Inc?
Le Propriété institutionnelle de Albireo Pharma Inc est 100.00%
Quelle est la définition de Propriété institutionnelle?
La propriété institutionnelle est le montant des actions disponibles d'une société détenues par des fonds mutuels ou des fonds de pension, des compagnies d'assurance, des sociétés d'investissement, des fonds de dotation ou d'autres grandes entités qui gèrent des fonds pour le compte de tiers.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Propriété institutionnelle des entreprises dans Health Care secteur sur NASDAQ par rapport à Albireo Pharma Inc
Que fait Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Entreprises avec propriété institutionnelle similaire à Albireo Pharma Inc
- Vonage Corp a Propriété institutionnelle de 99.92%
- Vonage Corp a Propriété institutionnelle de 99.92%
- Denbury a Propriété institutionnelle de 99.93%
- NOV Inc a Propriété institutionnelle de 99.95%
- Rhythm Pharmaceuticals a Propriété institutionnelle de 99.98%
- Spirit Realty Capital Inc a Propriété institutionnelle de 99.99%
- Albireo Pharma Inc a Propriété institutionnelle de 100.00%
- Atwood Oceanics a Propriété institutionnelle de 144.34%